Business model

Ayala Corporation partners with ING to secure sustainable finance €50 million, advancing healthcare growth in the Philippines

MANILA,Philippines,Dec. 18,2024-- Ayala Corporation signed a €50 million (₱3.1 Billion) social loan from leading European bank ING to support AC Health\'s portfolio growth.

12-19 Ayala Corporation

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model

In a head-to-head diet-induced obese (DIO) mouse study,ASC47 low dose combination 1 (ASC47,3 mg/kg,subcutaneous (SQ),once every four weeks plus semaglutide,30 nmol/kg,SQ,once daily),demonstrated super

12-19 Ascletis Pharma Inc.

WiMi Develops FPGA-Based Digital Quantum Computer Verification Technology

BEIJING,Dec. 18,2024-- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"),a leading global Hologram Augmented Reality ("AR") Technology provider,today anno

12-19 WiMi Hologram Cloud Inc.

State Grid Ningxia Electric Power Co., Ltd. Guyuan Branch provides efficient services to help the relocation of the forest farm

GUYUAN,China,Dec. 19,2024-- Recently,State Grid Ningxia Electric Power Co.,Ltd. Guyuan Branch has been highly praised by Sutai State-owned Forest Farm,Liupanshan Forestry Bureau,Guyuan City,Ningxia,fo

12-19 State Grid Ningxia Electric Power Co., Ltd. Guyuan Branch

GienTech transforms enterprise software testing with the launch of a powerful AI-driven end-to-end solution

Next-generation Testing Center of Excellence (TCoE 3.0) integrates AI,ML,and automation to make enterprise software testing faster,more responsive and efficient

12-19 GienTech

WuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years Collection

Leading GreenCRDMO Driven by Innovation for a Healthier Future Offering End-to-end Green Biologics Solutions for the Entire Industry

12-18

CureGene Received Clinical Trial Approval in China for CG-0255 for Injection - A Novel Antiplatelet Therapy

SHANGHAI,Dec. 12,2024-- CureGene Pharmaceutical ("CureGene"),a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antivir

12-18

Fujitsu develops world's first multi-AI agent security technology to protect against vulnerabilities and new threats

Collaboration among AI agents specialized in security with skills andknowledges of attacks and protection

12-18

MGSD Announces Results for 2024 Fiscal Year

NEW YORK,Dec. 13,2024-- Maitong Sunshine Cultural Development Co.,Ltd (OTCQB: MGSD),an enterprise that provides cultural tourism services and other related services and products,announced its financia

12-18

Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101

Company to conduct a Phase II multi-regional clinical trial (MRCT) for the treatment of Ulcerative Colitis (UC)

12-18